(Q55060474)

English

Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

author name string

J Rajfer

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

D J Handelsman

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

A Crum

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

B Steiner

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

M Peterson

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

R S Swerdloff

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

language of work or name

0 references

publication date

1 July 1986

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

46

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

104-110

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of gonadotropin-releasing hormone and its analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

LH and FSH responses to luteinizing-releasing hormone in normal, adult, human males

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of human spermatogenesis by depot androgen: Potential for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of an LHRH agonist and hCG on testicular steroidogenesis in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Stimulatory and Down-Regulatory Effects of a Gonadotropin-Releasing Hormone Agonist in Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical applications of LHRH and its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative activity, plasma elimination and tissue degradation of synthetic luteinizing hormone releasing hormone and certain of its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of circadian rhythmicity in blood testosterone levels with aging in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949466-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(16)49466-5

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/3087785

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55060474&oldid=1387208419"